The board consists of seven experienced professionals, bringing innovative insight to Medliminal's business strategy and the healthcare and information technology industries.
Jim Napoli has 21 years of legal experience holding titles of senior counsel and/or partner at three of the nation's leading law firms: Seyfarth Shaw, Proskauer Rose and McDermott, Will and Emery.
Currently, Jim Napoli serves as CEO of Medliminal.
Harry Fox has a well-established presence in the healthcare community, having held the positions of chief information officer at Kaiser Permanente and CareFirst BlueCross BlueShield.
Fox is the current chairman of the board of Whitman-Walker Health System. He places a focus on strategic planning, information technology, business operations, and cybersecurity.
Douglas Jacobsen is a lifelong entrepreneur with more than 30 years of experience in cultivating successful enterprises. Jacobsen received his bachelor's degree from UCLA and is a member of the Seneca-Cayuga Tribe of Oklahoma.
Norman Kravetz has over 46 years of experience in the Southern California real estate market and as the founder of Realty Bancorp Equities, LLC.
He is also the founder and owner of Kravetz Capital Funding and the owner of NJK Holding, LLC.
Joe Wilkins is a senior healthcare executive with an impressive tenure in the healthcare community.
Working with companies like Danaher–Beckman Coulter, Quest Diagnostics, and Atlantic Health System, Wilkins has always sought to bring transformation to the healthcare system.
Ginger Miller is currently the senior vice president of Operations at Intermedix and held a similar title while at Verisk Health.
Miller has also been recognized for her success in the industry by Utah's Business Forty under 40.
Brian Smith is an experienced healthcare sales professional. Smith is the founder and operations/sales leader of the five-person consulting firm, B. Castle Smith and Company.
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Enable Biosciences names new chief financial officer
Cadenza Bio names new director
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation